https://houstonhealthspan.com/wp-content/uploads/2019/05/Rejenevie-Khady-News-1030x687.jpg 687 1030 Webmaster https://houstonhealthspan.com/wp-content/uploads/2019/09/HHIG-logo-v2.svg Webmaster2019-05-29 00:58:482021-07-12 15:56:02Rejenevie™ Therapeutics Announces Start of Phase Ib Immune Restoration Treatment Clinical Trial
Rejenevie™ Therapeutics Announces Start of Phase Ib Immune Restoration Treatment Clinical Trial
Promising anti-aging stem cell therapy AR-100 shows potential in the treatment of age-related diseases
HOUSTON, May 29, 2019 — Rejenevie™ Therapeutics announced the commencement of the company’s Phase Ib clinical trial to study the safety and effectiveness of its proprietary AR-100 immune restoration therapy to boost the function of the aging immune system. The clinical-stage biotechnology company develops first-in-world stem cell restoration treatments targeting age-related diseases.